2022
DOI: 10.3389/fnins.2022.826021
|View full text |Cite
|
Sign up to set email alerts
|

Intravoxel Incoherent Motion Magnetic Resonance Imaging Used in Preoperative Screening of High-Risk Patients With Moyamoya Disease Who May Develop Postoperative Cerebral Hyperperfusion Syndrome

Abstract: ObjectiveThis study aimed to investigate the feasibility of preoperative intravoxel incoherent motion (IVIM) MRI for the screening of high-risk patients with moyamoya disease (MMD) who may develop postoperative cerebral hyperperfusion syndrome (CHS).MethodsThis study composed of two parts. In the first part 24 MMD patients and 24 control volunteers were enrolled. IVIM-MRI was performed. The relative pseudo-diffusion coefficient, perfusion fraction, apparent diffusion coefficient, and diffusion coefficient (rD*… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 48 publications
0
1
0
Order By: Relevance
“…Cerebral hyperperfusion syndrome (CHS) was characterized by extreme migraines, seizures, and new neurological deficiencies after the operation. CHS was also characterized by the absence of clear hematomas and the absence of distinct, intense areas of dead tissue on the cerebral MRI or/and CT images (10). We identified diabetes mellitus based on the demonstrative models from the Chinese Rules for the Counteraction and Treatment of Type 2 Diabetes Mellitus (11).…”
Section: Outcome Measuresmentioning
confidence: 99%
“…Cerebral hyperperfusion syndrome (CHS) was characterized by extreme migraines, seizures, and new neurological deficiencies after the operation. CHS was also characterized by the absence of clear hematomas and the absence of distinct, intense areas of dead tissue on the cerebral MRI or/and CT images (10). We identified diabetes mellitus based on the demonstrative models from the Chinese Rules for the Counteraction and Treatment of Type 2 Diabetes Mellitus (11).…”
Section: Outcome Measuresmentioning
confidence: 99%